Study on cenobamate and healthcare use in epilepsy
Part of Brain & nervous system clinical trials.
This study looks at how cenobamate (a medication for seizures) affects healthcare use, like hospital visits or emergency room trips, in people with epilepsy whose seizures were not well-controlled by 2 to 5 other medicines. It is a real-world study, meaning it uses medical records to understand the impact.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with epilepsy and your seizures start in one part of the brain (focal-onset seizures).
- You have already tried 2 to 5 different seizure medicines but they didn't control your seizures.
- You started taking cenobamate for the first time at a specific date (index date).
- In the 6 months before starting cenobamate, you had at least one seizure per month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well cenobamate works when added to other seizure medications for adults with focal epilepsy. It uses real-world data from medical records to see how people respond to treatment.
This trial studies the safety of cenobamate for Japanese people who have partial onset seizures and have already finished a previous study of the same drug. It helps doctors learn more about long-term safety.
This trial tests if a new seizure medicine called cenobamate can help control frequent or ongoing seizures in intensive care unit patients who are already on other seizure medications.
This trial tests whether a new seizure medicine (cenobamate) helps people whose seizures are caused by an overactive immune system. You would stay on your current treatments and add cenobamate to see if it reduces seizures.
This study tests a new medicine (ONO-2017) for people with a type of epilepsy that causes whole-body seizures. It looks at whether adding this drug to your current seizure medicines can reduce how often those seizures happen.
This study tests a new seizure medication called ONO-2017 in Japanese children and teenagers (ages 2–17) who have a specific type of seizure called POS that hasn't been controlled by current medicines. The goal is to see if this new drug is safe and helps reduce these seizures.
Hear when a new Epilepsy With Uncontrolled Focal-onset Seizures trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.